But the good news is that for fat to come back, the weight has to increase by a large amount
doi: 10.1038/sj.ijo.0801083 Summary Keywords Prader-Willi syndrome, obesity, GLP-1 receptor agonist, semaglutide, metabolic surgery Citation Koceva A, Mleku Kozamernik K, Jane A, Herman R, Ferjan S and Jensterle M (2025) Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
Now its backwith a prescription pad. Shrinking influencers and celebrities The evidence is everywhere
Retatrutide has shown promising diabetes management results in clinical trials, with significant improvements in blood sugar control and insulin sensitivity
Many patients find it challenging to navigate these programs without support